Form 4 for NVAX NOVAVAX INC
Accepted 2026-06-23 19:51:55 ET · period of report 2026-06-18 · accession 0001104659-26-076925 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-23 19:51 | 2026-06-20 | NVAX | MOTT DAVID M | Dir | M - OptEx | — | +18.9K | 79.8K | +31% | — |
| DM | 2026-06-23 19:51 | 2026-06-18 | NVAX | MOTT DAVID M | Dir | A - Grant | $0.00 | +35.5K | 14.2K | New | $0 |
| D | 2026-06-23 19:51 | 2026-06-20 | NVAX | MOTT DAVID M | Dir | M - OptEx | $0.00 | -18.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-20 | M | A | 18,880 | — | 79,770 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-06-18 | A | A | 21,270 | $0.00 | 21,270 | D | $9.13 · — to 2036-06-18 | 21,270 Common Stock | (F2) One hundred percent (100%) of the shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date. |
| 3 | Derivative | Restricted Stock Units | 2026-06-18 | A | A | 14,180 | $0.00 | 14,180 | D | — · — to — | 14,180 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. (F3) One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date. (F3) One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date. |
| 4 | Derivative | Restricted Stock Units | 2026-06-20 | M | D | 18,880 | $0.00 | 0 | D | — · — to — | 18,880 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. (F4) One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 20, 2025 grant date subject to continued service on the Company's Board of Directors through the vesting date. (F4) One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 20, 2025 grant date subject to continued service on the Company's Board of Directors through the vesting date. |